Nonnarcotic Analgesics in Short-term Pain: Musculoskeletal Disorders
Joseph Markenson, MD, FACP, FACR
Introduction
Injuries to the musculoskeletal system occurring in sports and at the workplace
are becoming more commonplace and, at the same time, the severity of such injuries
is increasing. The sequelae of such injuries may be complex and may encompass
significant social, economic, and psychological manifestations. Patients experiencing
significant pain may avoid engaging in the normal activities of daily living.
Whereas at one time most occupational injuries occurred as heavy machines were
being used, the advent of the computer has brought with it a new group of repetitive
motion injuries. Also, the types of injuries physicians are seeing has changed
because todays workplace includes more women, senior citizens, and physically
disabled workers, and each of these populations is particularly disposed to
developing a relatively unique set of injuries.
Occupational and recreational injuries together appear to be the greatest cause
of strains, sprains, tendonitis, and episodes of bursitis that result in short-term
pain (Table).1 Relief of pain is accomplished by means of a comprehensive
therapeutic approach making use of several modalities of care. For many patients,
the use of medication helps control the pain experienced and simultaneously
hastens the healing of the injury.
Regional rheumatic pain syndromes include disorders involving muscles, tendons,
enthesis joints, cartilage, ligaments, fascia, bone, and nerve. Many of these
syndromes are the result of injury from a specific event often an occupational
or recreational activity or an accident that may be a specific episode limited
in time or may be associated with repetitive overuse of the human body. The
occurrence of such syndromes may be secondary to abnormal body positions or
abnormal body mechanics. In addition, older persons experience an increased
incidence of injury as compared with younger individuals. The organic changes
associated with such an increase include tendons that become less flexible and
elastic with age and muscles that atrophy and decrease in bulk. The alteration
in the structure of muscles makes them less able to absorb mechanical force,
a phenomenon that can result in greater forces being transmitted to ligaments,
tendons, joints, and enthesis. Furthermore, the lack of adequate stretching,
disuse atrophy and genetic predisposition (hypermobility syndrome) in the elderly
may lead to variation in anatomy as well as to altered biomechanics. Such variations
and alterations may predispose older persons to injury and pain.2
The injuries being discussed occur most frequently in conjunction with occupational
and recreational activities.3 Occupational injuries severe enough
to confine a worker to bed for 24 to 48 hours number 2,779,000 annually, according
to a survey conducted by the US Public Health Service.4 Most of these
injuries are minor and include cuts, bruises, and strains of the extremities.
However, more disabling injuries also may originate in the workplace; among
these more serious injuries, those to the lower back and extremities predominate.4
Upper extremity, back, cervical spine, and repetitive stress injuries are the
most frequent forms of occupational injuries, in contrast to the lower extremity
injuries more commonly associated with athletic activities. Cumulative trauma
disorder which refers to tenosynovitis, carpal tunnel disorders, epicondylitis,
and rotator cuff injuries as well as to such less well defined entities as diffuse
back and para spinal complaints has grown more prevalent and now accounts
for more than 50% of all occupational injuries in the United States. The annual
incidence of cumulative trauma disorder is 21 cases per 1,000 workers.5
The economic impact of short-term injuries is difficult to assess. The National
Safety Council estimates that on an annual basis, 14.6 injuries occur for every
1,000 persons in the labor force. Furthermore, work-related injuries cost $45
billion per year in terms of both medical expenses and lost work time.5
During the past decades, Americans have placed increasing emphasis on preventive
health, and this change has been accompanied by more widespread regular exercise
throughout the population. In the United States, 22% of adults report that five
times a week they engage in regular, sustained physical activity of greater
or lesser intensity that lasts 30 minutes or more. Of these, 15% engage in regular
vigorous physical activity for at least 20 minutes three times a week. Exercise
has been shown to be of demonstrable value: according to the American Heart
Association, 250,000 deaths a year in the United States are attributable to
a lack of regular physical activity. Another striking fact is that risk of developing
high blood pressure among those Americans who are less physically active is
30% to 50% greater than for those who engage in greater amounts of physical
activity.6 An estimated 215 million Americans participate in at least
one recreational sport, such as running, walking, swimming, and bowling. Among
Americans 18 years of age or less, 7 million of 41 million participate in school
sports.
|
Regional
Pain Syndromes*
|
|
Shoulder region
|
Rotator cuff
tendinitis
|
|
|
Bicipital tendinitis
|
|
|
Adhesive capsulitis
|
|
Elbow
region
|
Olecranon bursitis
|
|
|
Medial and lateral epicondylitis
|
|
Wrist and hand
|
de Quervains
tenosynovitis
|
|
|
Wrist tenosynovitis
and carpal tunnel syndrome
|
|
|
Volar flexor
tenosynovitis
|
|
|
Dupuytrens contracture
|
|
Hip region
|
Trochanteric
bursitis
|
|
|
Iliopsoas bursitis
|
|
|
Ischial bursitis
|
|
Knee region
|
Anserine bursitis
|
|
|
Prepatellar bursitis
|
|
|
Popliteal tendinitis
|
|
|
Patellofemoral
pain syndromes
|
|
Ankle and foot region
|
Achilles tendinitis
|
|
|
Retrocalcaneal
bursitis
|
|
|
Plantar fasciitis
|
|
|
Tarsal tunnel
syndromes
|
|
|
Metatarsalgia
|
|
Costochondritis
|
|
Sports injuries
|
Bone contusion,
stress fractures, and avulsion injuries
|
|
|
Muscle and tendon
injuries
|
|
|
Ligament and
capsule injuries
|
|
Occupational injuries
|
Overuse syndromes
|
|
|
Low back pain
and lumbosacral disc disease
|
|
|
Cervical spine
injuries, whiplash, and radiculopathy
|
|
*For a
complete description of these entities, refer to Koopman WJ, ed. Arthritis
and Allied Conditions: A Textbook of Rheumatology. 13th ed. Baltimore,
Md: Williams & Wilkins; 1997.
|
However, whether it is adults or students who are participating in the physical
activity, many of those who exercise sustain injuries. For example, the 7 million
students who participate in school sports sustain approximately 10 to 12 million
injuries annually.7,8 Although injuries associated with recreational
activities constitute a significant problem in both younger persons and adults,
physicians and other health care professionals should encourage healthful recreational
activities.
Although musculoskeletal injuries occur in many environments and while the
incidence of such occupational and recreational injuries is particularly great,
the impact of subpopulations on the epidemiology of these injuries remains an
important consideration. Both the incidence and the character of musculoskeletal
disorders, for example, are affected by the numbers of women, senior citizens,
and physically disabled persons present in the work force and recreational environments.
Each population subgroup is prone to a particular set of injuries and is vulnerable
to certain social, economic, and psychological manifestations of disease. In
addition, it is important to note that all persons who work with computers are
at increased risk for developing repetitive motion injuries.
Nonsteroidal Anti-inflammatory Drugs
Nonsteroidal anti-inflammatory drugs (NSAIDs) are traditionally prescribed
for treatment of inflammation associated with chronic arthritis and treatment
of soft-tissue injury. The use of NSAIDs in the management of these conditions
relates to the combined analgesic, anti-inflammatory, and antipyretic properties
of these medicines. In addition to treating pain, NSAIDs undoubtedly decrease
soft-tissue inflammation and stiffness associated with acute injury.
Such injury causes cellular damage to the soft or connective tissues, and the
damage sets the stage for inflammation. Initial vasoconstriction is followed
by the release of the chemical mediators of inflammation: histamine and bradykinin
are released by mast cells and thromboxane, leukotrienes, and prostaglandins
are released by cell membranes.9 The inflammatory process is central
not only to pain mechanisms, increased pain sensation being a protective device,
but also to the repair process, for the chemical mediators of inflammation cause
increased cellular and capillary permeability and, simultaneously, stimulate
vasodilation.10 Activated white blood cells and macrophages are brought
into the area of tissue damage. Erythema, heat, pain, and swelling appear.
However, dysfunction may eventually result because although the inflammatory
response is essential to the resolution of the injury, excessive inflammation
with edema interrupts the flow of oxygen to healthy tissues. Hypoxia results,
and thus further tissue damage may occur.
NSAIDs block the formation of prostaglandins from arachidonic acid by inhibiting
the generation of the enzyme cyclooxygenase as a consequence of tissue damage,
a process described in Dr John Vanes Nobel-prize-winning research.11
These prostaglandins PGD2, PGE2, and PGF2
cause dilation of blood vessels and the leakage of fluid into surrounding
tissues. In conjunction with histamine, bradykinin, and other substances, these
prostaglandins cause pain.
The effects of NSAIDs on cartilage are more controversial. Cartilage does not
respond to injury with inflammation. Instead, the balance through which the
chondrocyte is constantly synthesizing to build blocks of collagen and matrix,
as well as to produce enzymes that degrade both collagen and the proteoglycan
matrix, is distorted. Following acute injury, the process of degradation may
gain greater prominence than that of synthesis. As a consequence, accelerated
secondary osteoarthritis may develop.
Evidence of the effects of NSAIDs on cartilage is conflicting. Some studies
show that salicylates and certain other NSAIDs suppress proteoglycan synthesis
in normal cartilage.12 Other studies demonstrate that NSAIDs reduce
the activity of degradative enzymes in cartilage and suppress cartilage catabolism.13,14
However, these studies were performed on uninjured cartilage and, therefore,
may or may not indicate how NSAIDs function in cartilage following acute injury.
In addition, researchers have not adequately studied the interesting conjecture
that the cytokines involved in inflammation stimulate the chondrocyte to secrete
degradative enzymes and that inhibition of inflammation thus may be chondroprotective
in acute injury.
Often the initial inflammatory reaction to acute injury is in excess of that
needed for healing. Therefore, it is beneficial that NSAIDs reduce soft-tissue
inflammation. They achieve this by affecting the production of cytokines and
super oxide radicals, the aggregation and adhesion of neutrophils, and the inhibition
of prostaglandins, as well as by impacting on other mechanisms. Whether or not
an NSAID should be used immediately following acute injury is controversial.
Some authorities argue that because these drugs block thromboxane, their early
use within 72 hours of the injury promotes additional bleeding and retards
healing. Others contend that the rapid inhibition of the inflammatory process
will diminish pain, decrease inflammation, and more quickly mobilize the patient.15
An excellent review summarizes the capabilities of NSAIDs to decrease the inflammation,
pain tenderness, and stiffness associated with soft-tissue injuries.16
Whether NSAIDs can hasten a return to work or sports and can promote restoration
of normal functioning following injury has not been well studied and remains
controversial. Animal studies suggest that during the healing process, NSAID
administration during the first six days postinjury helps to strengthen injured
ligaments.17 Additional research has demonstrated that treatment
with NSAIDs promotes the return of function following muscle strain.18
In contrast, other studies do not demonstrate the return of full function or
improved performance when NSAIDs are used following injury.19
The growing popularity of sports and exercise in the general population has
undoubtedly resulted in increased use of NSAIDs for acute injuries. Such use,
combined with rest, rehabilitation, and modification of activity, decreases
pain and hastens the patients return to normal activities.20
Conclusions
The incidence and severity of acute musculoskeletal injury have increased,
and many of these injuries are associated with occupational and recreational
activities. Increasing numbers of women, older persons, and physically disabled
persons in the workforce, as well as the large numbers of Americans who engage
in recreational exercise, are important factors associated with this increase.
The use of NSAIDs for the treatment of acute soft-tissue injuries is widespread.
Over 99 million prescriptions for these drugs are filled on an annual basis
in the United States, in addition to over-the-counter purchase of NSAIDs.21
Although the clinical indications for the use of NSAIDs for the treatment of
acute soft-tissue injuries has not been adequately defined,16 their
effectiveness for patients with musculoskeletal complaints is clear. In combination
with rest, rehabilitation, and modification of activity following acute soft-tissue
injuries, NSAIDs help to provide symptomatic relief. Accumulating evidence suggests
that they neither delay healing nor interfere with the repair of soft tissue
or cartilage following acute injury. Furthermore, in the nongeriatric population,
the use of NSAIDs as short-term therapy appears to be associated with neither
short-term nor long-term side effects.
References
1. Koopman WJ, ed. Arthritis and Allied Conditions: A Textbook of Rheumatology.
13th ed. Baltimore, Md: Williams & Wilkins; 1997:1770-1771.
2. Biundo JJ. Regional pain syndromes. In: Schumacher HR Jr, Klippel JH,
Koopman WJ, eds. Primer of Rheumatic Disease. Atlanta, Ga: Arthritis
Foundation; 1997.
3. Rock MG. Sports and occupational injuries. In: Schumacher HR Jr, Klippel
JH, Koopman WJ, eds. Primer of Rheumatic Disease. Atlanta, Ga: Arthritis
Foundation; 1997.
4. Accident Facts. Chicago, Ill: National Safety Council; 1983.
5. Reports on Survey of Occupational Injuries and Illnesses in 1977 Through
1989. Washington, DC: Bureau of Labor Statistics, US Department of Labor;
1990.
6. 1998 Heart and Stroke Statistical Update. Dallas, Tex: American
Heart Association; 1997.
7. Kraus JF, Conroy C. Mortality and morbidity from injuries in sports and
recreation. Annu Rev Public Health. 1984;5:163-192.
8. The epidemiology of sports injury. In: Birrer RB, ed. Sports Medicine
for the Primary Care Physician. 2nd ed. Boca Raton, Fla: CRC Press; 1994:253-265.
9. Teitz CC. Scientific Foundations of Sports Medicine. Philadelphia,
Pa: BC Decker; 1989.
10. Koester MC. The pharmacology of rehabilitation, theoretical and practical
considerations. In: Griffin LY, ed. Rehabilitation of the Injured Knee.
2nd ed. St. Louis, Mo: Mosby; 1995:45-46.
11. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action
for the aspirin-like drugs. Nat New Biol. 1971; 231:232-235.
12. Brandt KD, Palmoski MJ. Effects of salicylates and other nonsteroidal
anti-inflammatory drugs on articular cartilage. Am J Med. 1984;77:65-69.
13. Pelletier JP, Cloutier JM, Martel-Pelletier J. In vitro effects of tiaprofenic
acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of
human osteoarthritic cartilage. J Rheumatol. 1989;16:646-655.
14. Ratcliffe A, Azzo W, Saed-Nejad F, et al. In vivo effects of naproxen
on composition proteoglycan metabolism, and matrix metalloproteinase activities
in canine articular cartilage. J Orthop Res. 1993;11:163-171.
15. Weiler JM. Medical modifiers of sports injury. The use of nonsteroidal
anti-inflammatory drugs (NSAIDs) in sports soft tissue injury. Clin Sports
Med. 1992;11:625-644.
16. Buckwalter JA. Pharmacological treatment of soft-tissue injuries. J
Bone Joint Surg Am. 1995;77:1902-1914.
17. Dahners LE, Gilbert JA, Lester GE, et al. The effect of a nonsteroidal
anti-inflammatory drug on the healing of ligaments. Am J Sports Med.
1988;16:641-646.
18. Almekinders LC, Gilbert JA. Healing of experimental muscle strains and
the effects of nonsteroidal anti-inflammatory medication. Am J Sports Med.
1986;14:303-308.
19. Weiler JM, Albrights JP, Buckwalter JA. Nonsteroidal anti-inflammatory
drugs in sports medicine. In: Lewis AJ, Furst DE, eds. Nonsteroidal Anti-Inflammatory
Drugs. New York, NY: Dekker; 1987:71-88.
20. Knych ET. Anti-inflammatory agents. In: Thomas JA, ed. Drugs, Athletes,
and Physical Performance. New York, NY: Plenum Medical Book Co; 1988.
21. Kaplan B, Swain RA. NSAIDs: are there any differences? Arch Fam Med.
1993;2:1167-1174.
Dr Markenson is Professor of Clinical Medicine at the Cornell Medical College,
Hospital for Special Surgery, New York, NY. No significant relationship
exists between the author and the companies whose products are referenced in
this article. Dr Markenson is on the speakers bureau for Wyeth-Ayerst
who provided an educational grant to support this supplement.
Back
to Cancer Control Journal Volume 6 Number 2 Supplement